Clostridium botulinum serotype B: microbial genetics, toxin biosynthesis, current applications, and future prospects
Archives of Microbiology · 2026
DOI: 10.1007/s00203-025-04540-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Aditi Kulshreshtha und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioengineering and Food Technology, Shoolini University of Biotechnology and Management Sciences, Kasuali Hills, Solan, 173229, Himachal Pr…. Hauptthemen laut MEDLINE: Botulinum Toxins, Clostridium botulinum type B, Clostridium botulinum. Die Arbeit nennt 67 Literaturangaben.
Abstract (Originalsprache)
Clostridium botulinum serotype B (Group I and II) is a Gram-positive, anaerobic bacterium renowned for producing botulinum neurotoxin type B (BoNT/B), a potent zinc-dependent endopeptidase. This mini-review explores the microbiological and genetic foundations of BoNT/B-producing strains, emphasizing their taxonomic classification, genomic plasticity, and toxin gene cluster organization (e.g., bont/B, ntnh, ha). The review highlights the bacterium’s environmental adaptability, driven by horizontal gene transfer and plasmid- or phage-encoded toxin genes, which influence strain diversity and toxin functionality. Structurally, BoNT/B exhibits unique receptor-binding specificity, targeting synaptotagmin I/II and gangliosides, a trait governed by evolutionary adaptations in its heavy-chain domain. Beyond its well-documented neuromuscular blockade, BoNT/B demonstrates emerging therapeutic applications in autonomic disorders and pain management, rooted in its selective cleavage of vesicle-associated membrane protein (VAMP). The review also discusses biotechnological innovations, such as engineered C. botulinum strains and nanotechnology-enhanced delivery systems, to optimize toxin yield and clinical efficacy. By integrating microbial genetics with translational insights, this work underscores C. botulinum serotype B as a model organism for studying toxin evolution and a promising platform for next-generation neurotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Bioengineering and Food Technology, Shoolini University of Biotechnology and Management Sciences, Kasuali Hills, Solan, 173229, Himachal Pradesh, India.
- Faculty of Applied Sciences and Biotechnology, Shoolini University of Biotechnology and Management Sciences, Kasuali Hills, Solan, 173229, Himachal Pradesh, India.
- Faculty of Applied Sciences and Biotechnology, Shoolini University of Biotechnology and Management Sciences, Kasuali Hills, Solan, 173229, Himachal Pradesh, India. mk.azhar1@gmail.com.
Zitieren
APA
Kulshreshtha, A., Jana, S., Rana, R., & Khan, A. (2026). Clostridium botulinum serotype B: microbial genetics, toxin biosynthesis, current applications, and future prospects. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04540-8
Vancouver
Kulshreshtha A, Jana S, Rana R, Khan A. Clostridium botulinum serotype B: microbial genetics, toxin biosynthesis, current applications, and future prospects. Archives of Microbiology. 2026. doi:10.1007/s00203-025-04540-8
BibTeX
@article{Kulshreshtha2026,
author = {Kulshreshtha, Aditi and Jana, Sataditya and Rana, Ritika and Khan, Azhar},
title = {Clostridium botulinum serotype B: microbial genetics, toxin biosynthesis, current applications, and future prospects},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-025-04540-8}
}
EUVIMED